Need Help? Call 1­-866-­796-­7386
« back to stock screener

  EGRX stock: Eagle Pharmaceuticals Inc

Current Rating
Buy

Previous Rating:

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$75.01
Market Cap
1.38B
Sector
Health Care
Div. Growth
-
P/E
18.1
P/B
9.16
P/S
7.31
Dividend %
-
P/CF
-
P/FCF
39.2
Op. Cash Flow
53.2K
FCF
2.3
Op. Margin
28.10%
Net Margin
43.00%
ROE
71.30%
ROI
53.80%
ROA
51.00%
EPS Growth
-
Current Ratio
2.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Navidea Biopharmaceuticals Inc (NAVB) $0.45 - - 79.2M Strong Buy
Chembio Diagnostics Inc (CEMI) $6.80 - - 76.3M Strong Buy
Reliv International, Inc (RELV) $7.98 - - 12.1M Strong Buy
Retractable Technologies, Inc. (RVP) $1.10 - - 31.7M Strong Buy
MGC Diagnostics Corp (MGCD) $8.21 - - 37.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More